Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is APBI appropriate for patients with rare tumor histology (mucinous, medullary, or tubular) if they meet all other suitability criteria?
Answer from: Radiation Oncologist at Community Practice
If phenotype right then it is tubular and mutinous are ER positive low grade tumor and are good candidates for APBI.
Comments
Radiation Oncologist at Allegheny Health Network, Pittsburgh
Agreed, these patients are good candidates for APB...
Radiation Oncologist at Mallory Radiotherapy, PLLC
Hi, thanks for your replies! I asked this question...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Medullary is Associated with BRCA 1 mutation and c...
2481
2482
2483
Sign in or Register to read more
7005
Related Questions
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Is stage I B/L breast, ER+ cancer a contraindication to breast radiation omission after breast conservation surgery?
What is your approach to a tumor bed boost in early stage breast cancer patients with micrometastasis?
In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
What are your top takeaways in Radiation Oncology from SABCS 2024?
Do you recommend re-excision of a unifocal positive anterior margin at skin after lumpectomy in a patient with otherwise low risk breast cancer features?
Would you recommend PMRT in a patient with a triple negative cT2N0, ypT2N0 metaplastic breast cancer s/p NAC, mastectomy, and SLNB?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
Agreed, these patients are good candidates for APB...
Hi, thanks for your replies! I asked this question...
Medullary is Associated with BRCA 1 mutation and c...